TAG:
pathology coding
Labs Have Questions about Prostate Biopsy Policy
CEO SUMMARY: How will pathology laboratories respond to the publication of revised policies in how laboratories should file Medicare Part B claims for prostate biopsies? Not only will there be a sharp drop in the reimbursement paid for a 12-core prostate biopsy, but labs may be at increas…
Medicare Carrier Plans to Reject Molecular Claims
CEO SUMMARY: In September, Palmetto, a Medicare carrier serving California and seven other states, made public two draft local coverage determinations (LCDs) that revamp its coverage guidelines for molecular diagnostic tests (MDT) and laboratory-developed tests (LDT). All labs su…
CURRENT ISSUE
Volume XXVII, No. 15 – October 26, 2020
INDUSTRY LEADERS SHARE THEIR CONCERNS over CMS’ planned cuts to COVID-19 test payments and discuss their proposed strategies for COVID testing. Also, a pathology group reports lessons learned the hard way when it opened a brand-new clinical lab in the midst of the worst of the pandemic.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
